Kolon TissueGene, Inc.

Languages

  • English
  • Korean
  • English
  • About
    • Overview
    • History
    • Management Team
    • Board of Directors
    • Advisory Boards
  • Technology
    • Overview
    • TG-C
    • Publications
  • Product Pipeline
    • Overview
    • Applications
  • Clinical Trials
  • IR
    • Stock Data
    • PR
    • IR Material
    • Disclosure
    • Analyst Report
  • Partnering/Alliances
  • Contact

PR

IR

IR

  • Stock Data
  • PR
  • IR Material
  • Disclosure
  • Analyst Report

TissueGene Initiates Patient Enrollment for a Phase II Study of TG-C for Osteoarthritis of the Knee

May 19, 2011
    • 1
    • 2
    • 3
    • 4
    © 2025 Kolon TissueGene, Inc. All Rights Reserved.

    This information—including product information—is intended only for residents of the United States. The products discussed on this site may have different labeling in different countries.

    Privacy Policy Disclaimer Sitemap Ethical Management